What's New in Health and Life Sciences
News from the European Commission
EUROPA - Research and Innovation: What's New in Health and life sciences
EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Biosociety web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
An EU-funded project has generated key insights into how gene expression is regulated dynamically in certain cells of the immune system, opening up novel avenues for research to advance understanding of disease progression.
EU-funded researchers are developing innovative materials that could herald improvements in energy efficiency and the environment, as well as the fight against bacterial infections in patients.
EU-funded researchers have developed a carbon with tiny pores that could prevent infection of livers by intestinal bacteria - a common complication in chronic liver disease. The material could improve patients' quality of life and chances of survival, while reducing the use of antibiotics in managing the disease.
EU-funded researchers are working on novel, more effective contrast agents - the substances that make the contrast between, for example, muscle and bone, in MRI scans. This new level of detail will improve diagnostics and help ensure people receive the right treatment.
EU-funded scientists have conducted groundbreaking research into brain cells that control memory formation and recollection, offering the promise of novel treatments for a potentially fatal disease that has a particularly devastating impact on the lives of children and young adults.
New photonic microscopes, systems and techniques developed within the EU-backed PHOQUS project are shining a light on vital medical research bringing life sciences and physics closer together. Findings will have direct applications in medicine, especially for better disease diagnosis.
Brominated organic chemicals, man-made chemical compounds added to many consumer products to make them less flammable, have raised numerous health and environmental concerns in recent years. An EU-funded project is evaluating a commercially ready tool to test for the presence of these harmful substances and prevent them from affecting ecosystems and human health.
Healthcare costs across Europe are increasing, with an ageing population and the burden of treating chronic diseases consuming valuable resources. EU-funded researchers have used Model-Based Therapeutics (MBT) - a process whereby computer models of the human body, patient data and automation are combined - to create new treatments for common medical problems that improve patient well-being and save money.
New technology could soon revolutionise the treatment of liver failure: an innovative dialysis device is currently being trialled. It aims to greatly improve the outlook for patients, helping them to recover or supporting them while they wait for a transplant, say the EU-funded researchers taking this innovation forward.